Iams Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.72M Buy
6,777
+3,071
+83% +$716K 0.52% 60
2026
Q1
$907K Buy
3,706
+14
+0.4% +$3.26K 0.32% 96
2025
Q4
$765K Sell
3,692
-620
-14% -$123K 0.28% 104
2025
Q3
$800K Sell
4,312
-40
-0.9% -$6.85K 0.32% 86
2025
Q2
$665K Sell
4,352
-628
-13% -$96.5K 0.31% 88
2025
Q1
$826K Buy
4,980
+357
+8% +$55.9K 0.38% 79
2024
Q4
$669K Sell
4,623
-3,487
-43% -$540K 0.31% 87
2024
Q3
$1.31M Buy
8,110
+2
+0% +$319 0.65% 50
2024
Q2
$1.19M Buy
8,108
+1,167
+17% +$174K 0.65% 52
2024
Q1
$1.12M Buy
6,941
+406
+6% +$64.6K 0.69% 50
2023
Q4
$1.02M Sell
6,535
-466
-7% -$71.5K 0.66% 50
2023
Q3
$1.09M Buy
+7,001
New +$1.16M 0.75% 44
2023
Q2
Sell
-6,053
Closed -$977K 189
2023
Q1
$930K Buy
6,053
+2,435
+67% +$393K 0.77% 43
2022
Q4
$639K Buy
+3,618
New +$625K 0.65% 49

Other funds holding JNJ

Iams Wealth Management's JNJ Position: Q2 2026 in Review

Iams Wealth Management increased its Johnson & Johnson (JNJ) stake by 83% in Q2 2026, buying an estimated $716K and bringing the position to 6,777 shares worth $1.72M. The position accounts for 0.52% of the portfolio, ranked #60.

Iams Wealth Management first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Iams Wealth Management held 6,777 shares of Johnson & Johnson worth $1.72M as of Q2 2026.
  • Iams Wealth Management bought 3,071 Johnson & Johnson shares in Q2 2026, an estimated $716K.
  • Johnson & Johnson made up 0.52% of Iams Wealth Management's portfolio in Q2 2026, its #60 holding.
  • Iams Wealth Management first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Iams Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.